In Part 2 of the series, Naiberg discusses how cannabis business owners can protect new technologies and inventions through applying for a patent.
Richard Naiberg starts his series of articles with an in-depth look at how cannabis businesses should protect trade secrets.
Spain appears to be the second country where CBD is becoming broadly regulated outside the medical space. What does this mean for the burgeoning CBD market across Europe? If not other places?
State regulators sent a cease-and-desist letter to Good Chemistry for using pesticides, while the company claims they told the state they were using safe pesticides even before starting business in Massachusetts.
The Canadian LP is entering medical markets via trials and individualized patient imports in both the U.S. and the UK as it also gears up for the recreational market in Canada.
Health Canada, the Canadian military, sports organizations and provincial governments continue to issue (and revise) guidelines as the October market start looms.
Follow these guidelines to help your cannabis products stand out on the shelves.
The two organizations announced the first ever partnership between a lab accreditation body and a cannabis trade organization.
As the October 17 deadline looms, what is the state of provincial reform in Canada and who stands to have the most influence in local markets?
GW Pharmaceuticals’ eye-watering price tag for its new CBD drug might fly (temporarily) in the U.S., but in Europe, competition is being encouraged.
